Takeda Pharmaceutical Company v. Sun Pharma Global Fze

U.S. Court of Appeals for the Federal Circuit

Takeda Pharmaceutical Company v. Sun Pharma Global Fze

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS U.S.A., INC., TAKEDA PHARMACEUTICALS AMERICA, INC., Plaintiffs-Appellants

v.

SUN PHARMA GLOBAL FZE, SUN PHARMACEUTICAL INDUSTRIES, LTD., Defendants-Appellees ______________________

2016-2325 ______________________

Appeal from the United States District Court for the District of New Jersey in No. 3:14-cv-04616-MLC-TJB, Judge Mary L. Cooper. ______________________

JUDGMENT ______________________

ARLENE L. CHOW, Hogan Lovells US LLP, New York, NY, argued for plaintiffs-appellants. Also represented by ERIC J. LOBENFELD, THOMAS SCHMIDT.

MARK DAVID SCHUMAN, Carlson, Caspers, Vanden- burgh, Lindquist & Schuman, P.A., Minneapolis, MN, argued for defendants-appellees. Also represented by SAMUEL T. LOCKNER, JONATHAN CARPENTER, CAROLINE MARSILI. ______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (PROST, Chief Judge, NEWMAN and DYK, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

April 10, 2017 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Reference

Status
Unpublished